A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (RCTS) OF EGFR-TARGETED MONOCLONAL ANTIBODY (MAB) THERAPY IN ADVANCED COLORECTAL CANCER (ACRC): IMPACT OF K-RAS STATUS

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Vale, C, Tierney, J, Meade, A, Fisher, D, Kaplan, R, Adams, R, Maughan, T, Parmar, M
Ձևաչափ:	Journal article
Հրապարակվել է:	2009

Impact of K-ras status on the effects of EGFR-targeted monoclonal antibody (MAb) therapy in advanced colorectal cancer (ACRC): A systematic review and meta-analysis of randomized controlled trials (RCTs)
‌: Vale, C, և այլն
Հրապարակվել է: (2009)

THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
‌: Maughan, T, և այլն
Հրապարակվել է: (2010)

Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
‌: Maughan, T, և այլն
Հրապարակվել է: (2009)

Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis.
‌: Vale, C, և այլն
Հրապարակվել է: (2012)

Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
‌: Vale, C, և այլն
Հրապարակվել է: (2012)

ADDITION OF CETUXIMAB TO OXALIPLATIN-BASED COMBINATION CHEMOTHERAPY (CT) IN PATIENTS WITH K-ras WILD-TYPE ADVANCED COLORECTAL CANCER (ACRC): EFFECTS ON OVERALL SURVIVAL. MRC COIN (CR10) TRIAL RESULTS
‌: Adams, R, և այլն
Հրապարակվել է: (2009)

Intermittent Chemotherapy (CT) Plus Continuous or Intermittent Cetuximab (C) in the First-line Treatment of Advanced Colorectal Cancer (aCRC): Results of the Two-arm Phase II Randomised MRC COIN-B Trial
‌: Wasan, H, և այլն
Հրապարակվել է: (2011)

HIGH THROUGHPUT SOMATIC PROFILING OF THE RAS-RAF-MAP AND PI3K-PTEN-AKT PATHWAYS IN ADVANCED COLORECTAL CANCER AND CORRELATIONS WITH RESPONSE TO CETUXIMAB
‌: Smith, C, և այլն
Հրապարակվել է: (2010)

FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS and NRAS
‌: Adams, R, և այլն
Հրապարակվել է: (2016)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
‌: Beth O. Van Emburgh, և այլն
Հրապարակվել է: (2016-12-01)

Intermittent versus continuous oxaliplatin-based combination chemotherapy in patients with advanced colorectal cancer: a randomised non-inferiority trial (MRC COIN)
‌: Adams, R, և այլն
Հրապարակվել է: (2009)

Design and development of information portal for Asian Communication Resource Centre (ACRC).
‌: Yohanes Ramli.
Հրապարակվել է: (2008)

Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT Database
‌: Shuhei Suzuki, և այլն
Հրապարակվել է: (2024-12-01)

Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.
‌: Wood, G, և այլն
Հրապարակվել է: (2017)

Chemotherapy-free intervals for patients with metastatic colorectal cancer remain an option.
‌: Maughan, T, և այլն
Հրապարակվել է: (2010)

Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
‌: Xiaona Lu, և այլն
Հրապարակվել է: (2023-11-01)

CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?
‌: Thiago David Alves PINTO, և այլն
Հրապարակվել է: (2021-06-01)

Intra-tumoral Heterogeneity of KRAS and BRAF Mutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing
‌: Susan D. Richman, և այլն
Հրապարակվել է: (2011-01-01)

Optimizing sequential treatment with anti-EGFR and VEGF mAb in metastatic colorectal cancer: current results and controversies
‌: Chen DT, և այլն
Հրապարակվել է: (2019-02-01)

A phase I study of Tc-99m-h-R3 monoclonal antibody (DiaCIM (R)), a humanized monoclonal antibody (mAB) for imaging EGFR-positive malignancies.
‌: Reilly, R, և այլն
Հրապարակվել է: (2002)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
‌: Lockwood, C, և այլն
Հրապարակվել է: (1995)

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial
‌: Adams, R, և այլն
Հրապարակվել է: (2017)

EGFR FISH analysis in colorectal cancer as a tool in selecting patients for antiEGFR monoclonal antibodies therapy
‌: Mauro Moroni, և այլն
Հրապարակվել է: (2011-12-01)

IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies
‌: Gaoussou Sanou, և այլն
Հրապարակվել է: (2024-06-01)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
‌: Madi, A, և այլն
Հրապարակվել է: (2012)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: The MRC COIN trial
‌: Madi, A, և այլն
Հրապարակվել է: (2012)

INTERMITTENT VS. CONTINUOUS OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN THE MRC COIN TRIAL IN ADVANCED COLORECTAL CANCER: UPDATED EFFICACY RESULTS, QUALITY OF LIFE AND POTENTIAL PREDICTIVE FACTORS
‌: Adams, R, և այլն
Հրապարակվել է: (2010)

Multispecificity of a recombinant anti-ras monoclonal antibody
‌: Schrader, John W., և այլն
Հրապարակվել է: (2017)

THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
‌: Maughan, T, և այլն
Հրապարակվել է: (2010)

Essay 4. What kinds of efficacies evade randomised controlled trials (RCTs)?
‌: Alford, M
Հրապարակվել է: (2017)

Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
‌: Samantha I. Liang, և այլն
Հրապարակվել է: (2018-03-01)

Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
‌: Taciana Manso, և այլն
Հրապարակվել է: (2023-05-01)

Radiolabeling and biodistribution of monoclonal antibody (MAb) anti-CD20 with iodine-131
‌: Akinkunmi Ganiyu Akanji, և այլն
Հրապարակվել է: (2005-10-01)

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
‌: Adams, R, և այլն
Հրապարակվել է: (2008)

A NOVEL COLORECTAL CANCER SUSCEPTIBILITY SNP IN THE EIF3H PROMOTER INFLUENCES PATIENT SURVIVAL AND RESPONSE TO TREATMENT
‌: Cheadle, J, և այլն
Հրապարակվել է: (2010)

Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework
‌: Wilson, C, և այլն
Հրապարակվել է: (2018)

Epitope mapping of an anti-diacylglycerol kinase delta monoclonal antibody DdMab-1
‌: Masato Sano, և այլն
Հրապարակվել է: (2020-12-01)

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
‌: Adams, R, և այլն
Հրապարակվել է: (2011)

The use of healthcare systems data for RCTs
‌: Alice-Maria Toader, և այլն
Հրապարակվել է: (2024-01-01)

<it>EGFR</it> gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis
‌: Yang Zu-Yao, և այլն
Հրապարակվել է: (2012-08-01)

A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (RCTS) OF EGFR-TARGETED MONOCLONAL ANTIBODY (MAB) THERAPY IN ADVANCED COLORECTAL CANCER (ACRC): IMPACT OF K-RAS STATUS

Նմանատիպ նյութեր

Նմանատիպ նյութեր